| 1 | Nanotheranostics | 16.3 | 99th | Q1 | – | – | Yes |
| 2 | Marine Drugs | 11.6 | 97th | Q1 | SCIE | – | Yes |
| 3 | Journal of Pharmaceutical Investigation | 10.6 | 95th | Q1 | SCIE | – | No |
| 4 | Stresses | 10 | 93rd | Q1 | – | – | Yes |
| 5 | Frontiers in Toxicology | 7.5 | 92nd | Q1 | ESCI | – | Yes |
| 6 | Pharmaceutical Science Advances | 5.9 | 90th | Q1 | – | – | Yes |
| 7 | Pollutants | 5.2 | 88th | Q1 | ESCI | – | Yes |
| 8 | Addictive Behaviors Reports | 5.1 | 86th | Q1 | ESCI | – | Yes |
| 9 | Frontiers in Drug Discovery | 5 | 85th | Q1 | ESCI | – | Yes |
| 10 | Frontiers in Natural Products | 4.4 | 83rd | Q1 | – | – | Yes |
| 11 | Cancer Innovation | 4.4 | 81st | Q1 | ESCI | – | Yes |
| 12 | Therapeutic Innovation and Regulatory Science | 4.3 | 79th | Q1 | SCIE | – | No |
| 13 | Patient Preference and Adherence | 4 | 78th | Q1 | SCIE | – | Yes |
| 14 | Frontiers in Drug Safety and Regulation | 4 | 76th | Q1 | – | – | Yes |
| 15 | RSC Pharmaceutics | 3.8 | 74th | Q2 | ESCI | – | Yes |
| 16 | Biologics | 3.7 | 72nd | Q2 | – | – | Yes |
| 17 | Forensic Sciences | 3.3 | 71st | Q2 | ESCI | – | Yes |
| 18 | Value in Health Regional Issues | 3.3 | 69th | Q2 | ESCI | – | No |
| 19 | Acta Microbiologica et Immunologica Hungarica | 3.1 | 67th | Q2 | SCIE | – | No |
| 20 | International Journal of Pharmacy Practice | 2.9 | 65th | Q2 | ESCI | – | No |
| 21 | Iranian Journal of Medical Sciences | 2.6 | 64th | Q2 | ESCI | – | Yes |
| 22 | Science and Technology Indonesia | 2.5 | 62nd | Q2 | – | – | Yes |
| 23 | International Journal of Applied Pharmaceutics | 2.1 | 60th | Q2 | – | – | No |
| 24 | Research Results in Biomedicine | 2.1 | 58th | Q2 | – | – | No |
| 25 | Drug Delivery Letters | 1.9 | 57th | Q2 | – | – | No |
| 26 | Pharmacoepidemiology | 1.9 | 55th | Q2 | ESCI | – | Yes |
| 27 | Allergies | 1.8 | 53rd | Q2 | – | – | Yes |
| 28 | Frontiers in Chemical Biology | 1.7 | 51st | Q2 | – | – | Yes |
| 29 | Aging Pathobiology and Therapeutics | 1.6 | 50th | Q2 | – | – | No |
| 30 | Research Journal of Pharmacy and Technology | 1.5 | 48th | Q3 | – | – | No |
| 31 | Vitae | 1.5 | 46th | Q3 | – | – | Yes |
| 32 | Journal of Pharmaceutical Health Services Research | 1.4 | 44th | Q3 | ESCI | – | No |
| 33 | Natural and Life Sciences Communications | 1.4 | 42nd | Q3 | – | – | No |
| 34 | Open Access Journal of Clinical Trials | 1.2 | 41st | Q3 | ESCI | – | Yes |
| 35 | Dilemas | 1 | 39th | Q3 | – | – | Yes |
| 36 | International Journal of Advancement in Life Sciences Research | 0.9 | 37th | Q3 | – | – | No |
| 37 | Chinese Journal of Modern Applied Pharmacy | 0.8 | 35th | Q3 | – | – | No |
| 38 | International Journal of Minor Fruits, Medicinal and Aromatic Plants | 0.7 | 34th | Q3 | – | – | Yes |
| 39 | Safety and Risk of Pharmacotherapy | 0.7 | 32nd | Q3 | – | – | Yes |
| 40 | Journal of Applied Pharmaceutical Research | 0.7 | 30th | Q3 | – | – | Yes |
| 41 | Life Sciences, Medicine and Biomedicine | 0.6 | 28th | Q3 | – | – | Yes |
| 42 | Chinese Journal of Pharmacovigilance | 0.6 | 27th | Q3 | – | – | No |
| 43 | International Journal of Advanced Science and Engineering | 0.6 | 25th | Q3 | – | – | No |
| 44 | China Pharmacy | 0.6 | 23rd | Q4 | – | – | Yes |
| 45 | Uspehi Molekularnoj Onkologii | 0.6 | 21st | Q4 | – | – | No |
| 46 | Tromboz, Gemostaz i Reologiya | 0.5 | 20th | Q4 | – | – | No |
| 47 | Journal of Natural Remedies | 0.5 | 18th | Q4 | – | – | No |
| 48 | Vestnik Rossijskoj Voenno-Medicinskoj Akademii | 0.4 | 16th | Q4 | – | – | No |
| 49 | Farmacja Polska | 0.3 | 14th | Q4 | – | – | Yes |
| 50 | Pediatrics Eastern Europe | 0.3 | 13th | Q4 | – | – | No |
| 51 | European Health and Pharmaceutical Law Review | 0.2 | 11th | Q4 | – | – | No |
| 52 | Clinical and Translational Neuroscience | 0.2 | 9th | Q4 | ESCI | – | Yes |
| 53 | Asian Journal of Pharmaceutical and Clinical Research | 0.2 | 7th | Q4 | – | – | No |
| 54 | Edition Fachdidaktiken | 0.1 | 6th | Q4 | – | – | No |
| 55 | Regulatory Rapporteur | 0.1 | 4th | Q4 | – | – | No |
| 56 | Arzneimitteltherapie | 0 | 2nd | Q4 | – | – | No |
| 57 | Pharmaceutical Manufacturing and Packing Sourcer | 0 | 0th | Q4 | – | – | No |